Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Changes

26 Mar 2013 16:19

RNS Number : 9352A
Plant Health Care PLC
26 March 2013
 



 

26 March 2013

 

Plant Health Care plc

("Plant Health Care" or "the Company")

Board Changes 

Plant Health Care plc, ("PHC"),a leading provider of novel patent protected biological products to the global agriculture markets, is today announcing the appointment of a new Chief Executive Officer, among other Board changes.

 

After twelve years as CEO of Plant Health Care, John Brady will be stepping down on 2 April 2013. He will be succeeded by Paul Schmidt who will take over as CEO the same day.

 

John has provided outstanding leadership of the Company and the Board would like to pay tribute to his enormous contribution. The Board is delighted that the Company is retaining John's services as a non-executive director, in which role the Company will continue to benefit from his invaluable experience.

 

The Company is pleased to welcome Paul Schmidt. Mr Schmidt has extensive operational experience in the agriculture industry, having served in senior roles in the USA, Germany and Canada during 25 years with Bayer CropScience and its predecessor companies. As President of Merck/EMD Crop Bioscience, a leading developer of natural plant health products, Paul led a turn-around which resulted in substantially increased sales and profit. In February 2011, he oversaw the sale of the business to Novozymes for $275 million. Paul graduated from the University of Saskatchewan with a BSA in Agronomy in 1980.

 

Sam Wauchope, having served as a non-executive director for nine years, four of them as Senior Independent Director, will step down from the Board on 2 April 2013. The Board would like to thank Sam for the contribution he has made to the Company.

 

Michael Higgins will join the Company as the Senior Independent Director and Chair of the Audit Committee following the Company's AGM on 9 May 2013. He is currently non-executive Chairman of AIM quoted Ebiquity plc and Deputy Chairman of the Quoted Companies Alliance. Michael also works with, and invests in, a number of early-stage businesses. Michael was a Senior Adviser at KPMG following ten years as a Partner. Prior to KPMG, he was a Director at Charterhouse Bank, worked at Saudi International Bank and qualified as an accountant with Price Waterhouse (now PricewaterhouseCoopers).

 

Dr. Christopher Richards, Chairman commented: "I wish to place on record our appreciation of all that John has done for Plant Health Care; this Company is very much his personal creation. I am delighted that we are retaining John's services as a non-executive director, in which role we will continue to benefit from his invaluable experience. I would also like to take this opportunity to pay tribute to Sam for his contribution, which included a stint as Interim Chairman in 2012.

 

"Securing the services of Paul Schmidt as the Company's new CEO is a real coup. Paul's extensive experience in the industry leaves us very well positioned to progress to the next stage in the Company's development. I am convinced that Paul has the right qualities to lead Plant Health Care to this next level. We look forward to welcoming Michael to the Company and to the Board following our AGM. Michael will bring a wealth of additional experience that we will benefit from."

 

 

- ENDS -

 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets. The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/mnemonic: PHC).

Further information is available at: www.planthealthcare.com.

 

 For further information, please contact:

Plant Health Care plc

 

 

Dr Christopher Richards, Chairman

On the day Tel: +44 (0) 20 7250 1446

John Brady, Chief Executive Officer

On the day Tel: +44 (0) 20 7250 1446

Thereafter: Tel: +1-603-525-3702 

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

 

Nomura Code Securities

Chris Collins / Clare Terlouw / Chris Golden

Tel: +44 (0) 20 7776 1200

Powerscourt

Paul Durman / Nick Dibden / Sophie Moate

Tel: +44 (0) 20 7250 1446

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAJFMFTMBBTBJJ
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.